A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Study Identifier
11002X-001
CT.gov Identifier
NCT01664949
EudraCT Identifier
2012-002238-35
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • Carboxymethylcellulose Based Eye Drop Formulation A
  • Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Have used artificial tears for dry eye
    Exclusion Criteria:
    * Start date of over the counter, herbal, prescription or nutritional supplements that may affect dry eye or vision within 3 months prior to study start or an anticipated change in dosage during the study * History of eye surgery or trauma in the 6 months prior to study start * Current use or use within 2 weeks of study start, of topical eye medications.

    Protocol Summary

    This study will evaluate the safety and efficacy of a carboxymethylcellulose based eye drop formulation compared with carboxymethylcellulose based preservative-free lubricant eye drops (OPTIVE™) in subjects with dry eye disease.

    Study Locations

    Location
    Status
    Location
    Randwick, New South Wales, Australia
    Status
    Not applicable
    Location
    Leuven, Belgium
    Status
    Not applicable
    Location
    Marseille, France
    Status
    Not applicable
    Location
    Tours, France
    Status
    Not applicable
    Location
    Freiburg im Breisgau, Germany
    Status
    Not applicable
    Location
    Padova, Italy
    Status
    Not applicable
    Showing {first} - {last} of {total} Results